Evidence map›Paper›PMID 35780497›Full record

ArticleEndocrinology, diabetes & metabolism2022

Health-related quality of life of people with type 2 diabetes and its associated factors at a tertiary care clinic in Ningbo, China: A cross-sectional study.

Naomi Carter, Jialin Li, Miao Xu, Li Li, Xuelan Fan, Shuyan Zhu, Pritpal Chahal, Kaushik Chattopadhyay

Open access · goldAbstract read
In one paragraph

Article in Endocrinology, diabetes & metabolism, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
1.8field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Trial
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Naomi CarterLifespan and Population Health Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK.ORCID 0000-0001-7005-7916
Jialin LiDepartment of Endocrinology and Metabolism, Ningbo First Hospital, Ningbo, China.
Miao XuDepartment of Endocrinology and Metabolism, Ningbo First Hospital, Ningbo, China.
Li LiDepartment of Endocrinology and Metabolism, Ningbo First Hospital, Ningbo, China.
Xuelan FanDepartment of Endocrinology and Metabolism, Ningbo First Hospital, Ningbo, China.
Shuyan ZhuDepartment of Endocrinology and Metabolism, Ningbo First Hospital, Ningbo, China.
Pritpal ChahalLifespan and Population Health Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK.
Kaushik ChattopadhyayLifespan and Population Health Academic Unit, School of Medicine, University of Nottingham, Nottingham, UK.ORCID 0000-0002-3235-8168
Ningbo First Hospital · CNUniversity of Nottingham · GB

Funding

Department of Health NIHR301000
6 · The paper itself

Abstract

introductionThe burden of type 2 diabetes (T2DM) in China is increasing, with potential impacts on the health-related quality of life (HRQoL) of those who develop the disease. Context-specific assessment of HRQoL and its associated factors informs the development of contextually appropriate interventions to improve HRQoL. This study aimed to determine the HRQoL and its associated factors in people with T2DM at a tertiary care clinic in Ningbo, China.

methodsA cross-sectional survey was undertaken among 406 people with T2DM in 2020-21. The primary outcome was HRQoL measured using EQ VAS and EQ-5D index from the EQ-5D-3L questionnaire. Multivariable regression analysis was used to determine the factors associated with HRQoL scores.

resultsThe mean (± standard deviation) EQ VAS score was 68.7 (13.8). Median (interquartile range) EQ-5D index was 1 (0.027). Prevalence of problems in HRQoL domains was as follows: pain/discomfort (15.7%), anxiety/depression (13.3%), mobility (5.4%), self-care (3.5%) and managing usual activities (5.2%). The ≥60 years age group had a mean EQ VAS score 8.7 points higher (95% CI 3.4, 13.9; p < .001) than the 18-39 years age group. Those with T2DM >10 years had a mean EQ VAS score 8.6 points lower than those with a duration <1 year (-12.8, -4.4; p = .001). A T2DM duration >10 years was associated with a reduction in the EQ-5D index of 0.029 (-0.041, -0.016; p < .001) compared with a duration <1 year.

conclusionsDepression/anxiety and pain/discomfort are important domains of reduced HRQoL for this population. A longer duration of T2DM is associated with reduced HRQoL scores, including both EQ VAS and EQ-5D index. Increasing age may be counterintuitively associated with an increase in EQ VAS score in this population, potentially reflecting a 'paradox of aging' process. Future work should focus on developing, evaluating and implementing interventions to improve HRQoL in T2DM, such as strategies to manage pain and mental health conditions.

Indexed as

Diabetes Mellitus, Type 2Quality of LifeAdolescentAdultChinaCross-Sectional StudiesHealth StatusHumansPainTertiary Health CareYoung AdultChinadiabetes mellitus, type 2quality of life

Identifiers

PMID35780497
PMCPMC9471595
OpenAlexW4283787027

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.